Found "Medical Procedures": 266 results
Belt and Road: Cross-National Learning to Support Evidence-Informed Practice in Pediatric Healthcare
Beijing Children’s Hospital, Capital Medical University, National Centre for Children’s Health of China are committed to advancing skills in conducting comprehensive clinical evaluations of medicines. This commitment is evident through a variety of initiatives, including workshops, training, and aca
Cross-Country Conversations: Health Technology Assessment (HTA) Experiences from India and Thailand
India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co
Implementing Health Tech for UHC: Real-World Lessons from PMAC 2025
The rapid advancement of technology is reshaping global health, offering new opportunities to strengthen health systems. The Prince Mahidol Award Conference (PMAC) 2025, under the theme of “Harnessing Technologies in an Age of AI to Build a Healthier World,” provided invaluable insights into the com
Is AI the Answer? Exploring the Challenges and Solutions of AI in Strengthening Health Systems: Insights from PMAC 2025
At the recent Prince Mahidol Award Conference (PMAC) 2025, the Health Intervention and Technology Assessment Program (HITAP) Foundation hosted a side meeting on the role of artificial intelligence (AI) in healthcare. This meeting “Is AI a Panacea for the Health Sector? Navigating the Barriers to Ado
F.D.A. Expedites Review of New Uses for Anticlotting Drug
The Food and Drug Administration has agreed to give priority status to its review of three new uses for the anticlotting drug Xarelto, Johnson & Johnson announced Monday.The company is asking the agency to approve the drug to treat deep vein thrombosis and pulmonary embolism, and to prevent recu
EU agency lifts lid on drug data secrets
(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E
Lesley Griffiths defends civil servants on NHS report
Wales’ health minister says it was “entirely appropriate” for her civil servants to be in contact with the author of a report into the NHS.Lesley Griffiths defended emails between senior officials and the academic behind the report.Officials were also challenged about why local health boards thought
International health panel says treat all HIV infections
(Reuters) – An international health panel has recommended for the first time that all HIV patients be treated with antiretroviral drugs, even when the virus’s impact on their immune system is shown to be small.The nonprofit International Antiviral Society-USA cited new evidence that untreated infect
F.D.A. Approves Drugs for Cancer and Myeloma
New drugs for breast cancer and multiple myeloma won approval from the Food and Drug Administration on Friday, expanding options for patients in advanced stages of those diseases.The breast cancer drug, Afinitor from Novartis, seems to expand the time that endocrine therapy can keep the disease in c
Public Lecture on Disease control priorities: improving health and reducing poverty by Prof. Dean Jamison (Only 120 Seats available)
SpeakerProfessor Dean Jamison, Professor Emeritus, Global Health Principal Investigator, Disease Control Priorities NetworkDate: 23 August 2016Time: 16.30 – 18.00Venue: Richmond Hotel, NonthaburiNumber of participants: 120 seats availableOrganizer: Health Intervention and Technology Assessment Progr
10 / Page